文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Retrospective Study to Determine Diagnostic Utility of 6 Commonly Used Lung Cancer Biomarkers Among Han and Uygur Population in Xinjiang Uygur Autonomous Region of People's Republic of China.

作者信息

Yang-Chun Feng, Min Feng, Di Zhang, Yan-Chun Huang

机构信息

From the Clinical Laboratory Center, Tumor Hospital Affiliated to Xinjiang Medical University, Urumqi, People's Republic of China.

出版信息

Medicine (Baltimore). 2016 May;95(18):e3568. doi: 10.1097/MD.0000000000003568.


DOI:10.1097/MD.0000000000003568
PMID:27149479
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4863796/
Abstract

Early diagnosis was the main way to improve the survival rate of lung cancer patients. At present, the methods to diagnose lung cancer were varied, but early diagnosis of lung cancer was still difficult. In experimental and clinical studies, lung cancer related tumor markers were helpful to the early diagnosis of lung cancer. So far, there were many studies about lung cancer related tumor markers in China, but the subjects in these studies were almost the Han population. There were few studies about the Uygur population. Xinjiang was a multi-ethnic region in China, the ratios of Han and Uygur population were 40% and 45%, respectively. Xinjiang also was a high incidence area of lung cancer in China. The purpose of this study was to research the application of 6 tumor markers in Uygur and Han lung cancer patients in XinJiang, China.The study collected 342 cases who were diagnosed as lung cancer in Tumor Hospital Affiliated to XinJiang Medical University from May 2012 to December 2012. Serum concentrations of squamous cell carcinoma (SCC), cytokeratin fragment 19 (CYFRA21-1), carcino-embryonic antigen (CEA), carbohydrate antigen 125 (CA125), precursor of gastrin-releasing peptide (Pro-GRP), and neuron-specific enolase (NSE) were tested for every patient before radiation, chemotherapy, or surgery. The serum concentrations of SCC, CYFRA21-1, CEA, CA125, and Pro-GRP were assayed using the micro-particle luminescence analysis testing by the Abbott ARHCITECT i2000SR immunoanalyzer. NSE was assayed by the electrochemical luminescence analysis testing using Roche Cobas E601 electrochemical luminescence analyzer.Serum levels of SCC were different between 2 ethnic populations, smoking should be the influence factor to create the difference. Cluster analysis showed that the NSE and Pro-GRP were helpful to identify small cell lung cancer (SCLC), and CEA, CA125, SCC, CYFRA21-1 were beneficial to diagnose non-small cell lung cancer (NSCLC). The compare of diagnosis value about serum tumor markers also proved the result of cluster analysis. No matter SCLC or NSCLC, the positives rate of all tumor markers were increasing as clinical stage advancing. Pro-GRP had higher positive rate than NSE in limited stage of SCLC. CA125 had the highest positive rate in I and II stage of NSCLC, and CYFRA21-1 had the highest positive rate in III and IV stage of NSCLC. CEA and CA125 were beneficial to diagnose adenocarcinoma, CYFRA21-1, and SCC identified squamous cell cancer better.Only SCC level was higher in Han population than Uygur population because of the differences of smoking constituent ratio between 2 populations. So, it could be unified to research the application value of the 6 indicators for the Han and Uygur population. Then, we suggested a primary diagnostic utility of 6 commonly by lung cancer biomarkers in both the Han and Uygur populations in Xinjiang Uygur Autonomous Region of People's Republic of China.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15ef/4863796/5dbd43cbb784/medi-95-e3568-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15ef/4863796/a76ea17b559b/medi-95-e3568-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15ef/4863796/7e29318de327/medi-95-e3568-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15ef/4863796/dc16f910774a/medi-95-e3568-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15ef/4863796/c65a8a696cb7/medi-95-e3568-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15ef/4863796/5dbd43cbb784/medi-95-e3568-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15ef/4863796/a76ea17b559b/medi-95-e3568-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15ef/4863796/7e29318de327/medi-95-e3568-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15ef/4863796/dc16f910774a/medi-95-e3568-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15ef/4863796/c65a8a696cb7/medi-95-e3568-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15ef/4863796/5dbd43cbb784/medi-95-e3568-g009.jpg

相似文献

[1]
Retrospective Study to Determine Diagnostic Utility of 6 Commonly Used Lung Cancer Biomarkers Among Han and Uygur Population in Xinjiang Uygur Autonomous Region of People's Republic of China.

Medicine (Baltimore). 2016-5

[2]
The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited.

Cancer Biomark.

[3]
Association of CEA, NSE, CYFRA 21-1, SCC-Ag, and ProGRP with Clinicopathological Characteristics and Chemotherapeutic Outcomes of Lung Cancer.

Lab Med. 2023-7-5

[4]
Clinical evaluation and therapeutic monitoring value of serum tumor markers in lung cancer.

Int J Biol Markers. 2016-2-28

[5]
[Clinical Significance of Tumor Marker Detection in Patients 
with Advanced Squamous Cell Carcimoma of the Lung].

Zhongguo Fei Ai Za Zhi. 2016-10-20

[6]
Clinical Evaluation of Tumor Markers for Diagnosis in Patients with Non-small Cell Lung Cancer in China.

Asian Pac J Cancer Prev. 2015

[7]
Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer.

Life Sci. 2018-2-1

[8]
Diagnostic potential of protein serum biomarkers for distinguishing small and non-small cell lung cancer in patients with suspicious lung lesions.

Biomarkers. 2024-7

[9]
Dynamics of Serum Tumor Markers Can Serve as a Prognostic Biomarker for Chinese Advanced Non-small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors.

Front Immunol. 2020

[10]
The important role of circulating CYFRA21-1 in metastasis diagnosis and prognostic value compared with carcinoembryonic antigen and neuron-specific enolase in lung cancer patients.

BMC Cancer. 2017-2-2

引用本文的文献

[1]
Comprehensive insights and In silico analysis into the emerging role of LincRNAs in lung diseases pathogenesis; a step toward ncRNA precision.

Funct Integr Genomics. 2025-2-6

[2]
Determination of Tumor Marker Screening for Lung Cancer Using ROC Curves.

Dis Markers. 2024

[3]
Unsupervised machine learning method for indirect estimation of reference intervals for chronic kidney disease in the Puerto Rican population.

Sci Rep. 2023-10-11

[4]
Elevated preoperative CEA is associated with subclinical nodal involvement and worse survival in stage I non-small cell lung cancer: a systematic review and meta-analysis.

J Cardiothorac Surg. 2020-10-15

[5]
Tumour biomarkers: association with heart failure outcomes.

J Intern Med. 2020-8

[6]
Diagnostic Value of Combining Tumor and Inflammatory Markers in Lung Cancer.

J Cancer Prev. 2016-9

[7]
Knockdown of Long Noncoding RNA uc.338 by siRNA Inhibits Cellular Migration and Invasion in Human Lung Cancer Cells.

Oncol Res. 2016

本文引用的文献

[1]
Clinical significance of joint detection of serum CEA, SCCA, and bFGF in the diagnosis of lung cancer.

Int J Clin Exp Pathol. 2015-8-1

[2]
Emerging tobacco-related cancer risks in China: A nationwide, prospective study of 0.5 million adults.

Cancer. 2015-9-1

[3]
Clinical utility of haptoglobin in combination with CEA, NSE and CYFRA21-1 for diagnosis of lung cancer.

Asian Pac J Cancer Prev. 2014

[4]
US lung cancer trends by histologic type.

Cancer. 2014-9-15

[5]
Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer.

Cancer. 2013-12-16

[6]
Clinical evaluation and cost-effectiveness analysis of serum tumor markers in lung cancer.

Biomed Res Int. 2013-9-19

[7]
Epidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Chest. 2013-5

[8]
Serum tumor markers CEA, CYFRA21-1, and CA-125 are associated with worse prognosis in advanced non-small-cell lung cancer (NSCLC).

Clin Lung Cancer. 2011-4-24

[9]
Diagnostic value of pro-gastrin-releasing peptide for small cell lung cancer: a meta-analysis.

Clin Chem Lab Med. 2011-6

[10]
Are levels of pro-gastrin-releasing peptide or neuron-specific enolase at relapse prognostic factors after relapse in patients with small-cell lung cancer?

Lung Cancer. 2011-2

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索